Financial Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June Share by Ken Dropiewski on May 27, 2026 More in Financial: Terumo Neuro Signs Agreement to Acquire Arsenal Medical – Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH) September 30, 2026 AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readiness September 30, 2026 Elucid Appoints Mark Miller as Chief Revenue Officer to Lead Commercial Expansion Ahead of BioIntegrated FFR-CT Launch September 29, 2026 Share this story Facebook Twitter LinkedIn CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics will exhibit at four upcoming national benefits conferences. See the full post here as oringinally posted on this site.